DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ATENOLOL

« Back to Dashboard

Clinical Trials for Atenolol

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000478	Asymptomatic Cardiac Ischemia Pilot (ACIP) Study	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia.
NCT00000513	Trial of Antihypertensive Intervention Management	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	The objective of the Trial of Antihypertensive Intervention Management (TAIM) was to determine the efficacy of dietary management and/or drug therapy, namely thiazide-like diuretics or a beta-blocker, in the control of mild hypertension. Additionally, the Continuation of the Trial of Antihypertensive Intervention Management (COTAIM) tested the effects of long-term weight reduction, and sodium/potassium changes added to weight reduction, as well as the original drug treatment, on the failure rate of blood pressure control.
NCT00000514	Systolic Hypertension in the Elderly Program (SHEP)	Completed	National Institute on Aging (NIA)	Phase 3	The primary objective was to assess whether long-term administration of antihypertensive therapy to elderly subjects with isolated systolic hypertension reduced the combined incidence of fatal and non-fatal stroke. The secondary objectives were to evaluate: the effect of long-term antihypertensive therapy on mortality from any cause in elderly people with isolated systolic hypertension; possible adverse effects of chronic use of antihypertensive drug treatment in this population; the effect of therapy on indices of quality-of-life; the natural history of isolated systolic hypertension in the placebo population.

Clinical Trial Conditions for Atenolol

Condition Name

Condition Name for Atenolol
Intervention	Trials
Hypertension	37
Marfan Syndrome	6
Atrial Fibrillation	5

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Atenolol
Intervention	Trials
Hypertension	34
Coronary Artery Disease	7
Cardiovascular Diseases	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Atenolol

Trials by Country

Trials by Country for Atenolol
Location	Trials
United States	97
Canada	18
China	6
Germany	6
Korea, Republic of	6

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Atenolol
Location	Trials
Florida	8
Massachusetts	7
Minnesota	7
California	6
North Carolina	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Atenolol

Clinical Trial Phase

Clinical Trial Phase for Atenolol
Clinical Trial Phase	Trials
Phase 4	40
Phase 3	25
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Atenolol
Clinical Trial Phase	Trials
Completed	68
Unknown status	14
Recruiting	8

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Atenolol

Sponsor Name

Sponsor Name for Atenolol
Sponsor	Trials
National Heart, Lung, and Blood Institute (NHLBI)	6
University of Florida	4
Novartis	4

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Atenolol
Sponsor	Trials
Other	98
Industry	41
NIH	9

Export unavailable in trial.
Subscribe for complete access.